Initially, we analyzed the distribution of CD45-expressing cells negative for CD3, CD14, CD19 and CD20 (lineage negative) in the mucosa of patients with ACD, patients with ICD and controls. The gene discussed is CD19; the disease is granular corneal dystrophy type II.